Marijuana, also known as cannabis, has been used for medicinal purposes for centuries. Today, as more states and countries legalize medical marijuana, researchers are beginning to uncover the science behind its therapeutic properties. Medical marijuana works by interacting with the endocannabinoid system (ECS), a complex network of receptors and molecules found throughout the body.

The ECS is responsible for regulating a variety of physiological processes, including mood, appetite, pain sensation, and immune response. It consists of three main components: endocannabinoids (cannabinoids produced naturally by the body), receptors (proteins on the surface of cells that bind to cannabinoids), and enzymes (molecules that break down cannabinoids after they have been used).

When marijuana is consumed, its active compounds (called cannabinoids) bind to the receptors in the ECS, producing a range of effects. The two main cannabinoids in marijuana are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is responsible for the psychoactive effects of marijuana, such as euphoria, altered perception, and relaxation. CBD, on the other hand, does not produce a “high” and is thought to have a range of therapeutic benefits.

One of the ways medical marijuana works is by reducing inflammation. Inflammation is a natural response to injury or infection, but chronic inflammation can contribute to a range of health problems, including arthritis, heart disease, and cancer. THC and CBD both have anti-inflammatory properties, which can help reduce inflammation and associated pain.

Medical marijuana may also help regulate mood and anxiety. The ECS is involved in the regulation of mood, and studies have shown that THC and CBD can have antidepressant and anxiolytic (anti-anxiety) effects. THC has been shown to increase levels of the neurotransmitter serotonin, which is associated with feelings of well-being and happiness. CBD, on the other hand, may regulate anxiety by activating receptors in the ECS that are involved in the stress response.

In addition to reducing inflammation and regulating mood, medical marijuana may also have neuroprotective effects. Studies have shown that THC and CBD can protect brain cells from damage and may even promote the growth of new brain cells. This has led to interest in medical marijuana as a treatment for neurodegenerative diseases such as Alzheimer’s and Parkinson’s.

Medical marijuana may also help with pain management. THC is a potent analgesic, meaning it can relieve pain. Studies have shown that medical marijuana can be effective in treating chronic pain, including pain associated with cancer and multiple sclerosis. CBD, while not as potent as THC, may also have pain-relieving effects.

Medical marijuana has also been shown to have anti-convulsant effects. In fact, one of the most well-known medical uses of marijuana is in the treatment of epilepsy. THC and CBD both have anti-convulsant properties, and studies have shown that medical marijuana can reduce the frequency and severity of seizures in people with epilepsy.

Finally, medical marijuana may have anti-tumor effects. Studies have shown that THC and CBD can inhibit the growth and spread of certain types of cancer cells. While more research is needed to determine the full extent of medical marijuana’s anti-tumor effects, it is a promising area of study.

Overall, the science behind medical marijuana is complex and still evolving. However, studies have shown that it has a range of therapeutic benefits, including reducing inflammation, regulating mood and anxiety, protecting the brain, managing pain, reducing seizures, and potentially even fighting cancer. As research continues, medical marijuana may become an increasingly important tool in the treatment of a variety of health conditions.

1. Atakan, Z. (2012). Cannabis, a complex plant: Different compounds and different effects on individuals. Therapeutic Advances in Psychopharmacology, 2(6), 241-254. doi: 10.1177/2045125312457586

2. Huestis, M. A. (2007). Human cannabinoid pharmacokinetics. Chemistry & Biodiversity, 4(8), 1770-1804. doi: 10.1002/cbdv.200790152

3. Mechoulam, R., & Parker, L. A. (2013). The endocannabinoid system and the brain. Annual Review of Psychology, 64, 21-47. doi: 10.1146/annurev-psych-113011-143739

4. Russo, E. B. (2011). Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344-1364. doi: 10.1111/j.1476-5381.2011.01238.x

5. Russo, E. B. (2019). The case for the entourage effect and conventional breeding of clinical cannabis: No "strain," no gain. Frontiers in Plant Science, 9, 1969. doi: 10.3389/fpls.2018.01969

6. Stout, S. M., Cimino, N. M., & L. E. Lee. (2014). A systematic review of the antipsychotic properties of cannabidiol in humans. Schizophrenia Research, 153(1-3), 177-182. doi: 10.1016/j.schres.2014.08.012

7. Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370(23), 2219-2227. doi: 10.1056/NEJMra1402309

8. Zuardi, A. W. (2006). History of cannabis as a medicine: A review. Revista Brasileira de Psiquiatria, 28(2), 153-157. doi: 10.1590/S1516-44462006000200015

These references cover a range of topics related to the science of medical marijuana, including the chemical components of the cannabis plant, the pharmacokinetics of cannabinoids in the body, the endocannabinoid system, the entourage effect, the potential therapeutic benefits of cannabidiol, and the adverse health effects of marijuana use. They also provide historical context for the use of cannabis as a medicine.